NCT02172248View on ClinicalTrials.gov

Relative Bioavailability BI 10773 and Metformin in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

March 31, 2009

Conditions
Healthy
Interventions
DRUG

BI 10773

DRUG

Metformin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02172248 - Relative Bioavailability BI 10773 and Metformin in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter